All FAQs (Helpie FAQ)
Sample of All FAQs (Helpie FAQ) [helpie_faq]
New Search
If you are not happy with the results below please do another search
52 search results for:
Helpie FAQ – Group Sample
[helpie_notices group_id=’729’/] [helpie_faq group_id=’729’/]
Why Pharma Can’t Afford Good Enough AI
Why Pharma Can't Afford 'Good Enough' AI Generic AI tools like ChatGPT and Microsoft Copilot are rapidly being adopted across pharmaceutical organizations, with teams expecting them to handle complex use cases involving internal medical data. Yet despite their promise, these tools frequently fall short in pharmaceutical, biotech, and medtech environments. While they excel at general [...]
H2 2025 & 2026 AI Implementation Opportunities: Strategic Planning for Proven ROI in Pharma, Biotech & Medtech
As life sciences organizations allocate H2 2025 and 2026 budgets, the question isn't whether to invest in generative AI - it's how to implement it strategically for maximum impact. The Strategic Foundation: More Than Just Technology At FFI Ventures, we've learned that successful AI implementation requires a comprehensive approach that goes far beyond deploying tools. [...]
OneRay Key Updates Delivering Next-Generation GenAI Capabilities
OneRay Key Updates Delivering Next-Generation GenAI Capabilities Our private gen AI solution OneRay comes with significant updates in Version 3, introducing enhanced AI capabilities and an expanded suite of specialized agents for pharmaceutical knowledge work. We're pleased to share the key updates now available in OneRay Version 3, delivering a series of transformative enhancements [...]
Forum 2.0: Artificial Intelligence in Pharma
Forum 2.0: Artificial Intelligence in Pharma Register
Generative AI is set to transform medical affairs
Generative AI is set to transform medical affairs' strategic approach to patient impact. Generative AI is a transformative force reshaping how we approach patient care in Pharma, Biotech, and Medtech. At FFI Ventures, we’re leading this change, empowering and accelerating Medical Affairs teams as they transition from strategy design to real-world use case implementation. We’re [...]
Maximizing HCP engagement: the omnichannel advantage
Maximizing HCP engagement: the omnichannel advantage Coping with increasingly restrictive access to the audience, a vast range of different interests in products and services, and the average human attention span now reduced to a mere 8 seconds, pharmaceutical companies continue to build seamless, integrated customer experiences across preferred online and offline channels. The core objective [...]
Continuous Evolution and Value-Add of Our Gen AI Agents
Continuous Evolution and Value-Add of Our Gen AI Agents Our generative AI agents, or "bots" that we co-create with and implement in Pharma, Biotech & Medtech organizations are multi-talented, able to take on a wide range of business tasks and challenges. These agents are pre-trained and validated by domain experts before releasing to teams or [...]
Private generative AI is rapidly delivering value for Pharma
Private generative AI is rapidly delivering value for Pharma As companies make progress with generative AI, they are increasingly capturing and delivering value. Specific examples in 2024 include Lilly, Sanofi, Pfizer, Roche, Boehringer Ingelheim, Novo Nordisk and aiCure). Generative AI has the potential to revolutionize the pharma and biotech industry. By applying this technology to [...]